MedTrace Logo

Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN

NCT00831909 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3513

Last updated 2010-08-10

No results posted yet for this study

Summary

To provide accurate and reliable information regarding NSCLC clinical management across European countries in order to detect unmet medical needs of this disease in terms of: patient and hospital characteristics; diagnostic and treatment approaches: initial and subsequent, follow-up patterns in clinical management; outcomes: symptoms, death, functionality, quality of life; use of resources and burden on patients and health care systems.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Alfredo Carrato, MD · Hospital Ramón y Cajal, Madrid (Spain)

  • Esteban Medina · Medical Department, AstraZeneca Spain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Belgium
  • France
  • Germany
  • Greece
  • Italy
  • Portugal
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00831909 on ClinicalTrials.gov